Genome Canada’s Board of Directors welcomed three new members at its June 23, 2021 meeting.
Drawn from the academic, private and public sectors, Genome Canada Board Directors bring diverse experience and expertise to advance our mission to improve lives and strengthen communities through applied genomics research and innovation. Each Director is appointed for a two-year term, renewable up to a maximum of six years.
“We are thrilled to welcome three exceptional leaders to the Board as Genome Canada pursues a bold new strategic direction built on missions that generate solutions to today’s biggest global challenges.” – Dr. Elizabeth Douville, Chair of Genome Canada’s Board of Directors
“The breadth of experience Savage Bear, Ivo Gut and Éliane Ubaligoro bring to the table will help fuel Genome Canada’s impact in research and innovation to build stronger, healthier communities and drive environmental sustainability and prosperity. I’m privileged to work with such a skilled and dynamic Board of Directors.” – Dr. Rob Annan, President and CEO, Genome Canada
Meet Savage Bear, Ivo G. Gut and Éliane Ubalijoro who join the Board for two-year terms.
“The challenges that our planet faces are numerous and complex. As a compassionate, dedicated human, I seek out like minded individuals, groups and organizations that share the same vision; to make this world sustainable for future generations. I’m thrilled to work with Genome Canada as they demonstrate the same ethics, passion, and determination that supports innovative solutions to our global challenges.” – Dr. Tracy Bear
Dr. Savage Bear (formerly Tracy Bear) is a Nehiyaw’iskwew (Cree woman) from Montreal Lake First Nations and the new Director for the McMaster Indigenous Research Institute (MIRI) and an Assistant Professor with joint appointments in the Faculties of Social Sciences and Health Sciences at McMaster University.
“After serving on numerous Genome Canada review committees over the past 20 years, it is a great honor to join their Board of Directors. Genome Canada has always been a pioneer in guiding funding for genome research, particularly in areas of relevance to Canada. I look forward to contributing my expertise to the next phase of Genome Canada.” – Dr. Ivo G. Gut
Dr. Ivo G. Gut is Director of the Centro Nacional de Análisis Genómico (CNAG-CRG) based in Barcelona, one of the largest genome sequencing centres in Europe.
“I am delighted to join Genome Canada’s Board of Directors in this exciting phase of the organization’s development, including its role in kicking-off the Pan-Canadian Genomics Strategy announced in Budget 2021. The responsible and ethical use of genomics to help solve complex global challenges is needed more than ever as COVID-19 has demonstrated. With substantial new funding to kickstart this new phase, Genome Canada’s leadership to accelerate inclusive innovation that serves all of humanity and the planet can have even greater impact.” – Dr. Éliane Ubalijoro
Dr. Éliane Ubalijoro is the Executive Director of Sustainability in the Digital Age and the Canada Hub of Future Earth, a Professor of Practice for Public-Private Sector Partnerships at McGill University’s Institute for the Study of International Development and a Research Professor at Concordia University in the Department of Geography, Planning and Environment.